Annotation Detail for SLC27A4

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa03320 | PPAR signaling pathway |
Pathway ID | Pathway Name |
---|
| Transmembrane transport of small molecules |
Desease ID | Desease Name |
---|
1856 | Obesity |
Desease Name |
---|
Ichthyosis prematurity syndrome |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of SLC27A4 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of SLC27A4 mRNA | affects expression | 21346803
|
D001104 |
Arbutin |
Arbutin results in decreased expression of SLC27A4 mRNA | decreases expression | 17103032
|
D004281 |
Docosahexaenoic Acids |
PPARA protein promotes the reaction [Docosahexaenoic Acids results in increased expression of SLC27A4 mRNA] | increases expression|increases reaction | 18489776
|
D015118 |
Eicosapentaenoic Acid |
PPARA protein promotes the reaction [Eicosapentaenoic Acid results in increased expression of SLC27A4 mRNA] | increases expression|increases reaction | 18489776
|
D019301 |
Oleic Acid |
PPARA protein promotes the reaction [Oleic Acid results in increased expression of SLC27A4 mRNA] | increases expression|increases reaction | 18489776
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of SLC27A4 mRNA | increases expression | 18467677
|
C023036 |
perfluorooctanoic acid |
PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of SLC27A4 mRNA] | increases expression|increases reaction | 18467677
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC27A4 mRNA | affects binding|increases activity|increases expression | 18489776
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SLC27A4 mRNA | increases expression | 20059764 18467677 15375163 18301758
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of SLC27A4 mRNA] | increases expression|increases reaction | 18467677 20059764
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.28 | 7525203 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.82 | 16434500 |
MESH:D000860 |
Anoxia |
|
Oleic Acid |
6.23 | 15090967 |
MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
3.18 | 18582451 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.39 | 19483382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
1.78 | 16705839 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.76 | 14694615 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.00 | 19176532 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.37 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.32 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
4.90 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.30 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
4.30 | 21346803 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
7.79 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.79 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.01 | 19236843 20131406 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
9.74 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.74 | 19772884 18467677 16221962 19176532 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.04 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:C536271 |
Ichthyosis prematurity syndrome |
marker/mechanism |
|
| |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
3.17 | 12083418 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.17 | 16705839 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
5.24 | 17077332 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.57 | 8812269 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
3.45 | 17056761 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
4.95 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.95 | 16377806 15890375 20007298 |
MESH:D055370 |
Lung Injury |
|
Oleic Acid |
5.65 | 15090967 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.20 | 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.05 | 17405874 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.26 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.90 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
9.90 | 14694615 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
4.73 | 17132714 |
MESH:D011654 |
Pulmonary Edema |
|
Oleic Acid |
6.18 | 15090967 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oleic Acid |
5.61 | 18549715 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.68 | 18551238 |
MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
3.07 | 19015929 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.36 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.65 | 10091137 |